Unjha Formulations

Unjha Formulations Goodwill

The Goodwill of Unjha Formulations (531762.BO) as of Oct 27, 2026 is 5.00 M INR. In the previous year, Goodwill was 5.00 M INR — a change of 0.00% (lower).

Goodwill

5.00 MINR

YoY

0.00%

Last updated:

Goodwill of Unjha Formulations is 2026 5.00 M INR. Goodwill of Unjha Formulations was 2025 5.00 M INR. It decreases by 0.00% lower compared to the previous year.

The Unjha Formulations Goodwill history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill
Date
Goodwill
Jan 1, 2019
5.00 M INR
Jan 1, 2020
5.00 M INR
Jan 1, 2021
5.00 M INR
Jan 1, 2022
5.00 M INR
Jan 1, 2023
5.00 M INR
Jan 1, 2024
5.00 M INR
Jan 1, 2025
5.00 M INR
Jan 1, 2026
5.00 M INR
The Unjha Formulations Goodwill history
YEARGoodwillYoY
5.00 MINR0.00%
5.00 MINR0.00%
5.00 MINR0.00%
5.00 MINR0.00%
5.00 MINR0.00%
5.00 MINR0.00%
5.00 MINR0.00%
5.00 MINR0.00%
5.00 MINR0.00%
5.00 MINR0.00%
5.00 MINR0.00%
5.00 MINR0.00%
5.00 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Unjha Formulations Stock analysis

What does Unjha Formulations do? Unjha Formulations Ltd. generates revenue through the manufacturing and export of Ayurvedic products, primarily targeting international markets. The company's key products include Fibron SF Powder, Albendazole Bolus, and Fibermate, which are isabgol-based formulations. Anchor Sat-Isabgol, available in 50g, 100g, 200g, and 400g sizes, is a flagship product, while Fibron and Fibron SF (Sugar Free) come in 100g and 300g packages. The firm focuses on export markets for its veterinary medicinal formulations not for human use, alongside its Ayurvedic powder and tablet lines. The company's revenue streams are derived from the sale of Fibron SF Powder, Albendazole Bolus, and Fibermate to international buyers seeking Ayurvedic and veterinary products. Anchor Sat-Isabgol is sold in multiple sizes, catering to consumer demand for isabgol-based health supplements. Unjha Formulations Ltd. also produces Small Volume Ayurvedic Isabgol powder, which is exported globally. The primary customers are international importers and distributors specializing in Ayurvedic and veterinary medicinal products. Export markets drive the company's business model, with Fibron SF Powder and Fibron being key revenue contributors. The firm's veterinary medicinal formulation not for human use, including Albendazole Bolus, targets agricultural and livestock sectors. Anchor Sat-Isabgol's availability in various sizes ensures broad market reach, while the company's focus on isabgol-based formulations aligns with global demand for natural health products. Unjha Formulations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Unjha Formulations stock

Goodwill of Unjha Formulations is 5.00 M INR in 2026.

Goodwill of Unjha Formulations changed from 5.00 M INR to 5.00 M INR, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Goodwill Unjha Formulations since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's Unjha Formulations historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Unjha Formulations

All Key Metrics — Unjha Formulations